A biparatopic anti-EGFR nanobody efficiently inhibits solid tumour growth-Reference-Cited by-同舟云学术

A biparatopic anti-EGFR nanobody efficiently inhibits solid tumour growth

Published:2011-08-08 Issue:8 Volume:129 Page:2013-2024
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Roovers Rob C.,Vosjan Maria J.W.D.,Laeremans Toon,el Khoulati Rachid,de Bruin Renée C.G.,Ferguson Kathryn M.,Verkleij Arie J.,van Dongen Guus A.M.S.,van Bergen en Henegouwen Paul M.P.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference47 articles.

1. Crystal structure of a truncated epidermal growth factor receptor extracellular domain bound to transforming growth factor alpha;Garrett;Cell,2002

2. Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains;Ogiso;Cell,2002

3. Structure-based view of epidermal growth factor receptor regulation;Ferguson;Annu Rev Biophys,2008

4. The EGFR family and its ligands in human cancer. Signalling mechanisms and therapeutic opportunities;Yarden;Eur J Cancer,2001

5. Epidermal growth factor receptor: mechanisms of activation and signalling;Jorissen;Exp Cell Res,2003

Cited by 223 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of EGFR binding hotspots for design of new EGFR inhibitory biologics;Protein Science;2024-09-14

2. Self-reporting photodynamic nanobody conjugate for precise and sustainable large-volume tumor treatment;Nature Communications;2024-08-13

3. Research progress of serum albumin in the field of drug delivery;Interdisciplinary Medicine;2024-07

4. Site-specific tethering nanobodies on recombinant adeno-associated virus vectors for retargeted gene therapy;Acta Biomaterialia;2024-07

5. Development of a new EGFR-VHH-CAR T-cell therapy for treatment of esophageal squamous cell carcinoma;2024-06-25